Rehmann Capital Advisory Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.07M Buy
5,876
+169
+3% +$60.2K 0.11% 142
2025
Q4
$1.87M Sell
5,707
-296
-5% -$93.9K 0.1% 147
2025
Q3
$1.69M Sell
6,003
-2,934
-33% -$851K 0.09% 153
2025
Q2
$2.5M Sell
8,937
-69
-0.8% -$19.5K 0.15% 104
2025
Q1
$2.81M Buy
9,006
+535
+6% +$158K 0.18% 99
2024
Q4
$2.21M Buy
8,471
+109
+1% +$32.3K 0.14% 115
2024
Q3
$2.7M Buy
8,362
+20
+0.2% +$6.54K 0.18% 103
2024
Q2
$2.61M Sell
8,342
-193
-2% -$56.7K 0.19% 102
2024
Q1
$2.43M Buy
8,535
+176
+2% +$51.5K 0.18% 103
2023
Q4
$2.41M Buy
8,359
+278
+3% +$75.7K 0.2% 97
2023
Q3
$2.17M Buy
8,081
+1,214
+18% +$303K 0.2% 92
2023
Q2
$1.52M Buy
6,867
+99
+1% +$23K 0.14% 121
2023
Q1
$1.64M Buy
6,768
+434
+7% +$107K 0.15% 119
2022
Q4
$1.66M Buy
6,334
+67
+1% +$18K 0.17% 114
2022
Q3
$1.41M Buy
6,267
+377
+6% +$91.4K 0.16% 121
2022
Q2
$1.43M Sell
5,890
-652
-10% -$160K 0.16% 121
2022
Q1
$1.58M Buy
6,542
+1,365
+26% +$314K 0.15% 123
2021
Q4
$1.16M Sell
5,177
-479
-8% -$101K 0.11% 176
2021
Q3
$1.21M Buy
5,656
+45
+0.8% +$10.4K 0.11% 160
2021
Q2
$1.37M Buy
5,611
+125
+2% +$30.8K 0.13% 131
2021
Q1
$1.37M Buy
5,486
+254
+5% +$60.6K 0.14% 122
2020
Q4
$1.2M Buy
5,232
+402
+8% +$92.7K 0.14% 122
2020
Q3
$1.23M Buy
4,830
+85
+2% +$21.1K 0.16% 117
2020
Q2
$1.12M Buy
+4,745
New +$1.08M 0.15% 121
2019
Q3
$890K Buy
4,597
+291
+7% +$55.9K 0.11% 101
2019
Q2
$794K Sell
4,306
-269
-6% -$48.2K 0.1% 169
2019
Q1
$869K Sell
4,575
-23
-0.5% -$4.39K 0.12% 142
2018
Q4
$895K Sell
4,598
-15
-0.3% -$2.93K 0.13% 86
2018
Q3
$956K Buy
4,613
+17
+0.4% +$3.35K 0.13% 130
2018
Q2
$848K Sell
4,596
-1,268
-22% -$224K 0.12% 143
2018
Q1
$1M Buy
5,864
+1,223
+26% +$225K 0.16% 114
2017
Q4
$807K Sell
4,641
-70
-1% -$12.4K 0.14% 135
2017
Q3
$878K Buy
4,711
+1,239
+36% +$220K 0.16% 120
2017
Q2
$598K Sell
3,472
-1,497
-30% -$243K 0.11% 155
2017
Q1
$815K Sell
4,969
-41
-0.8% -$6.81K 0.14% 136
2016
Q4
$733K Buy
5,010
+131
+3% +$19.7K 0.13% 143
2016
Q3
$814K Sell
4,879
-2,225
-31% -$376K 0.16% 119
2016
Q2
$1.08M Sell
7,104
-85
-1% -$13.2K 0.2% 98
2016
Q1
$1.08M Buy
7,189
+156
+2% +$23.2K 0.21% 95
2015
Q4
$1.14M Buy
7,033
+25
+0.4% +$3.93K 0.24% 82
2015
Q3
$969K Buy
7,008
+254
+4% +$40K 0.22% 91
2015
Q2
$1.04M Buy
6,754
+224
+3% +$35.9K 0.24% 83
2015
Q1
$1.04M Buy
6,530
+443
+7% +$69.8K 0.24% 85
2014
Q4
$970K Buy
6,087
+1,233
+25% +$192K 0.22% 91
2014
Q3
$682K Buy
4,854
+33
+0.7% +$4.31K 0.16% 116
2014
Q2
$571K Buy
4,821
+50
+1% +$5.79K 0.14% 128
2014
Q1
$588K Sell
4,771
-17
-0.4% -$2.06K 0.16% 119
2013
Q4
$546K Sell
4,788
-35
-0.7% -$3.98K 0.17% 121
2013
Q3
$540K Sell
4,823
-56
-1% -$6.07K 0.17% 113
2013
Q2
$481K Buy
+4,879
New +$506K 0.17% 113

Other funds holding AMGN

Rehmann Capital Advisory Group's AMGN Position: Q1 2026 in Review

Rehmann Capital Advisory Group increased its Amgen (AMGN) stake by 3% in Q1 2026, buying an estimated $60.2K and bringing the position to 5,876 shares worth $2.07M. The position accounts for 0.11% of the portfolio, ranked #142.

Rehmann Capital Advisory Group first reported a position in AMGN in Q2 2013 and has held it in 50 quarters since. The position peaked at $2.81M in Q1 2025. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Rehmann Capital Advisory Group held 5,876 shares of Amgen worth $2.07M as of Q1 2026.
  • Rehmann Capital Advisory Group bought 169 Amgen shares in Q1 2026, an estimated $60.2K.
  • Amgen made up 0.11% of Rehmann Capital Advisory Group's portfolio in Q1 2026, its #142 holding.
  • Rehmann Capital Advisory Group first reported a position in Amgen in Q2 2013 and has held it in 50 quarters since.
  • Rehmann Capital Advisory Group's Amgen position peaked at $2.81M in Q1 2025.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Rehmann Capital Advisory Group's 13F filing for Q1 2026, filed 15 May 2026.